Illumina (NASDAQ:ILMN) Raised to Neutral at Citigroup

Citigroup upgraded shares of Illumina (NASDAQ:ILMN – Free Report) from a sell rating to a neutral rating in a research note released on Monday, MarketBeat Ratings reports. Citigroup currently has $120.00 target price on the life sciences company’s stock, up from their previous target price of $85.00. A number of other research firms have also […]

Leave a Reply

Your email address will not be published.

Previous post Equitable (NYSE:EQH) Upgraded to “Buy” at Jefferies Financial Group
Next post Howie Carr: Mayor dreaming of a non-white Christmas